Presentation is loading. Please wait.

Presentation is loading. Please wait.

Prevnar Supply Update Peter R. Paradiso, Ph.D. Wyeth Vaccines.

Published byJocelin Brooks Modified over 9 years ago

Similar presentations

Presentation on theme: "Prevnar Supply Update Peter R. Paradiso, Ph.D. Wyeth Vaccines."— Presentation transcript:

1 Prevnar Supply Update Peter R. Paradiso, Ph.D. Wyeth Vaccines

2 Prevnar Supply Update As of April 21, 2003… Prevnar is out of backorder!

3 010203

4 Source: SDI Vaccination Audit March 2003 n=2,859 2002 2003

5 Annual Incidence of Invasive Pneumococcal Disease in Vaccinated and Unvaccinated Children (NCKP) April 1996 – March 2002 Vaccine Serotypes <2 yr <1 yr <5 yr Prevnar Licensed

6 9.27 30.34 8.70 2.41 2.13 Rate After April 00-Mar 02 Cases/100,000 p-y <0.00118% (10, 26)11.37All > 5 yo 0.02614% (2, 25)35.3960+ 0.09915% (-3, 30)10.2040-59 <0.00158% (41, 71)5.7220-39 0.38818% (-27, 48)2.605-19 P-value Percent Reduction (95% CI) Rate Prior April 95- Mar 00 Cases/100,000 p-y Age Group (yrs) Impact of the Use of Prevnar ® in Children on Invasive Pneumococcal Disease in Older Children & Adults

7 Factors Effecting Vaccine Supply: Solutions For Manufacturers Create redundancies in critical manufacturing pathways (e.g. fill/finish) Be diligent in compliance updates (e.g. anticipate change)

8 Factors Effecting Vaccine Supply: Solution For users/purchasers Recognize value: it will lure manufacturers Create redundancies (e.g. stock piles) Pay attention to liability issues – emphasize the benefits (healthcare and cost)

9 Source: SDI Vaccination Coverage Audit 2000 2001 2002 Prevnar Supply Update Prevnar Vaccination Coverage (Infant Series) Backorder exceeds 1.0 million doses

Download ppt "Prevnar Supply Update Peter R. Paradiso, Ph.D. Wyeth Vaccines."

Similar presentations

Target Product Profile and technical requirements Pre-tender Meeting Pneumococcal Vaccines under the AMC Unicef Supply Division, Copenhagen 26 August.

Target Product Profile and technical requirements Pre-tender Meeting Pneumococcal Vaccines under the AMC Unicef Supply Division, Copenhagen 26 August.
Prevnar 13™ Pneumococcal 13-valent conjugate vaccine

Prevnar 13™ Pneumococcal 13-valent conjugate vaccine
1 Vaccines and Related Biological Products Advisory Committee Meeting November 18, 2009 Prevnar 13 Pneumococcal 13-valent Conjugate Vaccine [Diphtheria.

1 Vaccines and Related Biological Products Advisory Committee Meeting November 18, 2009 Prevnar 13 Pneumococcal 13-valent Conjugate Vaccine [Diphtheria.
Rotavirus vaccine impact. Introduction. Rotavirus vaccines lead to significant reductions in severe and fatal diarrhea in both vaccinated and unvaccinated.

Rotavirus vaccine impact. Introduction. Rotavirus vaccines lead to significant reductions in severe and fatal diarrhea in both vaccinated and unvaccinated.
Children Aged 5 to

Children Aged 5 to
An Approach to Demonstration of Effectiveness

An Approach to Demonstration of Effectiveness
2014 UPDATES FROM THE CDC’S ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP) William Schaffner, MD Professor of Preventive Medicine and Infectious Diseases.

2014 UPDATES FROM THE CDC’S ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP) William Schaffner, MD Professor of Preventive Medicine and Infectious Diseases.
Rotavirus Vaccine & Health Care Utilization for Diarrhea in U.S Children N Engl J Med 2011;365:1108-17 Vanessa Craven Clinical Research Fellow.

Rotavirus Vaccine & Health Care Utilization for Diarrhea in U.S Children N Engl J Med 2011;365: Vanessa Craven Clinical Research Fellow.
Vaccines and Related Biological Products Advisory Committee Meeting

Vaccines and Related Biological Products Advisory Committee Meeting
Pneumococcal Disease and Pneumococcal Vaccines Epidemiology and Prevention of Vaccine- Preventable Diseases National Immunization Program Centers for Disease.

Pneumococcal Disease and Pneumococcal Vaccines Epidemiology and Prevention of Vaccine- Preventable Diseases National Immunization Program Centers for Disease.
Pneumococcal Disease and Pneumococcal Vaccines Epidemiology and Prevention of Vaccine- Preventable Diseases National Immunization Program Centers for Disease.

Pneumococcal Disease and Pneumococcal Vaccines Epidemiology and Prevention of Vaccine- Preventable Diseases National Immunization Program Centers for Disease.
Hot Topics in Pediatric ID Robert J. Leggiadro, MD Chairman Department of Pediatrics Lincoln Medical Center Professor of Clinical Pediatrics Weill Medical.

Hot Topics in Pediatric ID Robert J. Leggiadro, MD Chairman Department of Pediatrics Lincoln Medical Center Professor of Clinical Pediatrics Weill Medical.
Jan T. Poolman, Ph.D. Director, Bacterial Vaccines R&D

Jan T. Poolman, Ph.D. Director, Bacterial Vaccines R&D
Various other updates Presented by: Karen S Ginsbury March 2012 1.

Various other updates Presented by: Karen S Ginsbury March
Vaccines and Related Biological Products Advisory Committee Meeting

Vaccines and Related Biological Products Advisory Committee Meeting
Incidence of Influenza in Ontario Following the Universal Influenza Immunization Campaign Dianne Groll PhD, University of Ottawa David J Thomson PhD, Queen’s.

Incidence of Influenza in Ontario Following the Universal Influenza Immunization Campaign Dianne Groll PhD, University of Ottawa David J Thomson PhD, Queen’s.
Impact of the Pneumococcal Conjugate Vaccines (PCV) on the burden of invasive pneumococcal disease (IPD) in Ireland Data source: National Pneumococcal.

Impact of the Pneumococcal Conjugate Vaccines (PCV) on the burden of invasive pneumococcal disease (IPD) in Ireland Data source: National Pneumococcal.
Basis for Developing a Pneumococcal Conjugate Vaccine for Adults George R. Siber, MD Executive Vice President and Chief Scientific Officer Wyeth Vaccines.

Basis for Developing a Pneumococcal Conjugate Vaccine for Adults George R. Siber, MD Executive Vice President and Chief Scientific Officer Wyeth Vaccines.
Indication for Otitis Media FDA Vaccine and Related Biologicals Advisory Committee Meeting May 21, 2002 Pneumococcal 7-Valent Conjugate Vaccine (Diphtheria.

Indication for Otitis Media FDA Vaccine and Related Biologicals Advisory Committee Meeting May 21, 2002 Pneumococcal 7-Valent Conjugate Vaccine (Diphtheria.
1 1 Immunization Update 2011 Connecticut Immunization Teleconference April 19, 2011 William Atkinson, MD, MPH National Center for Immunization and Respiratory.

1 1 Immunization Update 2011 Connecticut Immunization Teleconference April 19, 2011 William Atkinson, MD, MPH National Center for Immunization and Respiratory.

Similar presentations

Ads by Google